1 Min Read
NEW YORK, Nov 20 (Reuters) - BioMarin Pharmaceutical Inc : * Pharma up 6.1 percent premarket after FDA panel backs approval of Morquio A
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.